219 related articles for article (PubMed ID: 9569056)
1. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
Cheah PY; Cao X; Eu KW; Seow-Choen F
Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
3. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
Lindmark G
Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
[TBL] [Abstract][Full Text] [Related]
4. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
5. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
6. Early stage human colorectal cancer: prognostic value of nm23-H1 protein overexpression.
Indinnimeo M; Giarnieri E; Stazi A; Cicchini C; Brozzetti S; Valli C; Carreca I; Vecchione A
Cancer Lett; 1997 Jan; 111(1-2):1-5. PubMed ID: 9022121
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of nm23-H1 expression in colorectal carcinomas.
Dursun A; Akyürek N; Günel N; Yamaç D
Pathology; 2002 Oct; 34(5):427-32. PubMed ID: 12408341
[TBL] [Abstract][Full Text] [Related]
8. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
9. High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.
Zeng ZS; Hsu S; Zhang ZF; Cohen AM; Enker WE; Turnbull AA; Guillem JG
Br J Cancer; 1994 Nov; 70(5):1025-30. PubMed ID: 7947079
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
[TBL] [Abstract][Full Text] [Related]
11. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of nm23 protein expression in renal cell carcinomas.
Nakagawa Y; Tsumatani K; Kurumatani N; Cho M; Kitahori Y; Konishi N; Ozono S; Okajima E; Hirao Y; Hiasa Y
Oncology; 1998; 55(4):370-6. PubMed ID: 9663430
[TBL] [Abstract][Full Text] [Related]
13. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.
Yamaguchi A; Urano T; Fushida S; Furukawa K; Nishimura G; Yonemura Y; Miyazaki I; Nakagawara G; Shiku H
Br J Cancer; 1993 Nov; 68(5):1020-4. PubMed ID: 8217591
[TBL] [Abstract][Full Text] [Related]
14. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.
Srivatsa PJ; Cliby WA; Keeney GL; Dodson MK; Suman VJ; Roche PC; Podratz KC
Gynecol Oncol; 1996 Mar; 60(3):363-72. PubMed ID: 8774640
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal of the role of NM23-H1 in colorectal cancers.
Lee JC; Lin YJ; Chow NH; Wang ST
J Surg Oncol; 2001 Jan; 76(1):58-62. PubMed ID: 11223826
[TBL] [Abstract][Full Text] [Related]
16. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
[TBL] [Abstract][Full Text] [Related]
17. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
18. NM23 gene product expression does not predict lymph node metastases or survival in young patients with colorectal cancer.
Heys SD; Langlois N; Smith IC; Walker LG; Eremin O
Oncol Rep; 1998; 5(3):735-9. PubMed ID: 9538187
[TBL] [Abstract][Full Text] [Related]
19. Nm23-H1 protein, DNA-ploidy and S-phase fraction in relation to overall survival and disease free survival in transitional cell carcinoma of the bladder.
Alderisio M; Cenci M; Valli C; Russo A; Bazan V; Dardanoni G; Cucciarre S; Carreca I; Macaluso MP; Tomasino RM; Vecchione A
Anticancer Res; 1998; 18(6A):4225-30. PubMed ID: 9891471
[TBL] [Abstract][Full Text] [Related]
20. Nm23 'anti-metastatic' gene product expression in colorectal carcinoma.
Royds JA; Cross SS; Silcocks PB; Scholefield JH; Rees RC; Stephenson TJ
J Pathol; 1994 Mar; 172(3):261-6. PubMed ID: 8195929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
